Indications
- Perimenopause: Patients who are in the transitional phase leading up to menopause, experiencing irregularities in ovulation and hormone fluctuations that affect fertility.
- Low ovarian reserve: Patients who possess a diminished number of eggs in their ovaries, reducing their chances for natural conception relative to their age.
- Low levels of anti-Müllerian hormone (AMH): Patients whose blood tests show decreased levels of AMH, suggesting a reduced number of developing follicles in the ovaries and potentially compromised fertility potential.
- Premature ovarian failure: Patients whose ovaries have ceased to function normally before the age of 40, leading to a decrease in estrogen production and a limited number of available eggs for fertilization.
- Previous failure in assisted reproduction technique due to insufficient response in ovarian hyperstimulation: Patients who, despite undergoing fertility treatments like IVF and receiving medications to stimulate the ovaries, did not produce an adequate number of mature eggs for successful fertilization.